Home > Insider Trading > Filing (0001140361-10-035544)

Filing Details

Accession Number:: 0001140361-10-035544
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-08-30 17:14:41
Reporting Period:: 2010-08-26

Filing Date:: 2010-08-30
Accepted Time:: 2010-08-30 17:14:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885725	Boston Scientific Corp	BSX	Surgical & Medical Instruments & Apparatus (3841)	042695240

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
901458	M Peter Nicholas	C/O Boston Scientific Corp One Boston Scientific Place Natick MA 01760-1537		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-08-26	25,000	$5.36	7,206,021	No	4	S	Indirect	By Ltd. Partnership

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Ltd. Partnership

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Forward Sale Contract (obligation to sell)	Acquisiton	2010-08-26	18,277	$0.00	18,277	$0.00
Common Stock	Forward Sale Contract (obligation to sell)	Acquisiton	2010-08-26	65,724	$0.00	65,724	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
18,277	2012-08-27	2012-08-27	No	4	J	Indirect
65,724	2012-08-27	2012-08-27	No	4	J	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	9,212,125	Direct
Common Stock	2,413,088	Indirect	By Trust 2

Footnotes

Sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
The weighted average sales price is reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $5.47 to $5.32. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
Shares held by a trust of which the reporting person's spouse and brother are trustees and the reporting person's spouse and children are beneficiaries.
On March 1, 2010, a family limited partnership of which the reporting person is a general and limited partner, Promerica L.P., entered into a Rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. Under the contract reported on this form, Promerica will deliver to the bank up to 18,277 shares of the Issuer's common stock depending on market prices at maturity on August 27, 2012. If the market price per share at maturity is equal to or less than the floor price of $5.3650 per share, Promerica will deliver 18,277 shares to the bank. If the market price per share at maturity is greater than the floor price, Promerica will deliver a fewer number of shares. In exchange, the bank is obligated to pay $66,678.15 to Promerica two business days after the date of the contract. At the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
Promerica pledged 18,277 shares of the Issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge. The reporting person disclaims beneficial ownership of this stock except to the extent of his pecuniary interest.
On March 1, 2010, a family trust, of which the reporting person's spouse and brother are trustees and the reporting person's spouse and children are beneficiaries, entered into a Rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. Under the contract reported on this form, the trust will deliver to the bank up to 65,724 shares of the Issuer's common stock depending on market prices at maturity on August 27, 2012. If the market price per share at maturity is equal to or less than the floor price of $5.3650 per share, the trust will deliver 65,724 shares to the bank. If the market price per share at maturity is greater than the floor price, the trust will deliver a fewer number of shares. In exchange, the bank is obligated to pay $239,774.30 to the trust two business days after the date of the contract.
At the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
The family trust pledged 65,724 shares of the Issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.